{"transactions":[{"id":4635358,"issuer":{"id":8065,"kind":"organization","name":"Evogene Ltd."},"owners":[{"id":58121,"kind":"person","name":"Percy Adrian John","position":1,"cik":"0001980816","reported_name":"Percy Adrian John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-09-30T08:07:28.000Z","date":"2026-09-04","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options to purchase Ordinary Shares of the Issuer (the \"Options\") is New Israeli Shekels (\"NIS\") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options under the Issuer's 2021 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Options vest and become exercisable on a quarterly basis (25% per quarter) commencing on the grant date of September 4, 2026, such that they will be fully vested by September 4, 2027, the one-year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":0.58,"expiration_date":"2036-09-04","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001178913-26-004660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326004660/ownership.xml","form_type":"4"}}]}